WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced a 1-for-50 reverse stock split of its common ...

Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing the tuspetinib (TUS)-based triple drug frontline therapy to treat ...

Hedge fund Viking Global Investors is shifting its sector focus and signaling a possible hesitation towards Big Tech in the market.

Welcome back to the Money blog. Insurers reveal the kitchen appliance responsible for increasing numbers of claims. Meanwhile ...

January 2025, the U.S. Securities and Exchange Commission (SEC) approved amendments, both of which are now effective, to The Nasdaq Stock Market ...

Windtree Therapeutics (WINT) board of directors has approved a 1-for-50 reverse stock split of the Company’s common stock. The Company’s ...

Additional information about the reverse stock split can be found in the Current Report on Form 8-K filed today and in the Company’s definitive proxy statement (Form DEF 14A) filed with the United ...

Apple CEO Tim Cook all but told investors to circle their calendars for Wednesday, Feb. 19, 2025 in a recent social media ...

The New York Stock Exchange (NYSE) adopted an amendment (the “Amendment”) to the reverse stock split rules and procedures in ...

Just five sell-side analysts rate Apple Inc.’s stock at the equivalent of sell, counting Jefferies’ Edison Lee, who turned bearish late Monday. Lee has three reasons for his pessimism ...